Global Nofetumomab Merpentan Market Research Report 2016

December 2016 | 109 pages | ID: GE323A6A57EEN
QYResearch

Abstracts

Notes:

Production, means the output of Nofetumomab Merpentan

Revenue, means the sales value of Nofetumomab Merpentan

This report studies Nofetumomab Merpentan in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Merck
• GE Healthcare
• AREVA Med
• Bayer HealthCare Pharmaceuticals
• Cardinal Health
• Immunomedics
• Lantheus Medical Imaging
• Avid Radiopharmaceuticals
• Navidea
• Lantheus Medical

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Nofetumomab Merpentan in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Nofetumomab Merpentan in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Nofetumomab Merpentan Market Research Report 2016

1 NOFETUMOMAB MERPENTAN MARKET OVERVIEW

1.1 Product Overview and Scope of Nofetumomab Merpentan
1.2 Nofetumomab Merpentan Segment by Type
  1.2.1 Global Production Market Share of Nofetumomab Merpentan by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Nofetumomab Merpentan Segment by Application
  1.3.1 Nofetumomab Merpentan Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Nofetumomab Merpentan Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Nofetumomab Merpentan (2011-2021)

2 GLOBAL NOFETUMOMAB MERPENTAN MARKET COMPETITION BY MANUFACTURERS

2.1 Global Nofetumomab Merpentan Production and Share by Manufacturers (2015 and 2016)
2.2 Global Nofetumomab Merpentan Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Nofetumomab Merpentan Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Nofetumomab Merpentan Manufacturing Base Distribution, Sales Area and Product Type
2.5 Nofetumomab Merpentan Market Competitive Situation and Trends
  2.5.1 Nofetumomab Merpentan Market Concentration Rate
  2.5.2 Nofetumomab Merpentan Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL NOFETUMOMAB MERPENTAN PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Nofetumomab Merpentan Production and Market Share by Region (2011-2016)
3.2 Global Nofetumomab Merpentan Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL NOFETUMOMAB MERPENTAN SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Nofetumomab Merpentan Consumption by Regions (2011-2016)
4.2 North America Nofetumomab Merpentan Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Nofetumomab Merpentan Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Nofetumomab Merpentan Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Nofetumomab Merpentan Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Nofetumomab Merpentan Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Nofetumomab Merpentan Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL NOFETUMOMAB MERPENTAN PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Nofetumomab Merpentan Production and Market Share by Type (2011-2016)
5.2 Global Nofetumomab Merpentan Revenue and Market Share by Type (2011-2016)
5.3 Global Nofetumomab Merpentan Price by Type (2011-2016)
5.4 Global Nofetumomab Merpentan Production Growth by Type (2011-2016)

6 GLOBAL NOFETUMOMAB MERPENTAN MARKET ANALYSIS BY APPLICATION

6.1 Global Nofetumomab Merpentan Consumption and Market Share by Application (2011-2016)
6.2 Global Nofetumomab Merpentan Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL NOFETUMOMAB MERPENTAN MANUFACTURERS PROFILES/ANALYSIS

7.1 Merck
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Nofetumomab Merpentan Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Merck Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 GE Healthcare
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Nofetumomab Merpentan Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 GE Healthcare Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 AREVA Med
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Nofetumomab Merpentan Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 AREVA Med Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Bayer HealthCare Pharmaceuticals
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Nofetumomab Merpentan Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Bayer HealthCare Pharmaceuticals Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Cardinal Health
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Nofetumomab Merpentan Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Cardinal Health Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Immunomedics
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Nofetumomab Merpentan Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Immunomedics Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Lantheus Medical Imaging
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Nofetumomab Merpentan Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Lantheus Medical Imaging Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Avid Radiopharmaceuticals
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Nofetumomab Merpentan Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Avid Radiopharmaceuticals Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Navidea
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Nofetumomab Merpentan Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Navidea Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Lantheus Medical
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Nofetumomab Merpentan Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Lantheus Medical Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview

8 NOFETUMOMAB MERPENTAN MANUFACTURING COST ANALYSIS

8.1 Nofetumomab Merpentan Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Nofetumomab Merpentan

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Nofetumomab Merpentan Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Nofetumomab Merpentan Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL NOFETUMOMAB MERPENTAN MARKET FORECAST (2016-2021)

12.1 Global Nofetumomab Merpentan Production, Revenue Forecast (2016-2021)
12.2 Global Nofetumomab Merpentan Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Nofetumomab Merpentan Production Forecast by Type (2016-2021)
12.4 Global Nofetumomab Merpentan Consumption Forecast by Application (2016-2021)
12.5 Nofetumomab Merpentan Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Nofetumomab Merpentan
Figure Global Production Market Share of Nofetumomab Merpentan by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Nofetumomab Merpentan Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Nofetumomab Merpentan Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Nofetumomab Merpentan Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Nofetumomab Merpentan Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Nofetumomab Merpentan Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Nofetumomab Merpentan Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Nofetumomab Merpentan Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Nofetumomab Merpentan Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Nofetumomab Merpentan Production of Key Manufacturers (2015 and 2016)
Table Global Nofetumomab Merpentan Production Share by Manufacturers (2015 and 2016)
Figure 2015 Nofetumomab Merpentan Production Share by Manufacturers
Figure 2016 Nofetumomab Merpentan Production Share by Manufacturers
Table Global Nofetumomab Merpentan Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Nofetumomab Merpentan Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Nofetumomab Merpentan Revenue Share by Manufacturers
Table 2016 Global Nofetumomab Merpentan Revenue Share by Manufacturers
Table Global Market Nofetumomab Merpentan Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Nofetumomab Merpentan Average Price of Key Manufacturers in 2015
Table Manufacturers Nofetumomab Merpentan Manufacturing Base Distribution and Sales Area
Table Manufacturers Nofetumomab Merpentan Product Type
Figure Nofetumomab Merpentan Market Share of Top 3 Manufacturers
Figure Nofetumomab Merpentan Market Share of Top 5 Manufacturers
Table Global Nofetumomab Merpentan Production by Regions (2011-2016)
Figure Global Nofetumomab Merpentan Production and Market Share by Regions (2011-2016)
Figure Global Nofetumomab Merpentan Production Market Share by Regions (2011-2016)
Figure 2015 Global Nofetumomab Merpentan Production Market Share by Regions
Table Global Nofetumomab Merpentan Revenue by Regions (2011-2016)
Table Global Nofetumomab Merpentan Revenue Market Share by Regions (2011-2016)
Table 2015 Global Nofetumomab Merpentan Revenue Market Share by Regions
Table Global Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
Table China Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
Table India Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Nofetumomab Merpentan Consumption Market by Regions (2011-2016)
Table Global Nofetumomab Merpentan Consumption Market Share by Regions (2011-2016)
Figure Global Nofetumomab Merpentan Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Nofetumomab Merpentan Consumption Market Share by Regions
Table North America Nofetumomab Merpentan Production, Consumption, Import & Export (2011-2016)
Table Europe Nofetumomab Merpentan Production, Consumption, Import & Export (2011-2016)
Table China Nofetumomab Merpentan Production, Consumption, Import & Export (2011-2016)
Table Japan Nofetumomab Merpentan Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Nofetumomab Merpentan Production, Consumption, Import & Export (2011-2016)
Table India Nofetumomab Merpentan Production, Consumption, Import & Export (2011-2016)
Table Global Nofetumomab Merpentan Production by Type (2011-2016)
Table Global Nofetumomab Merpentan Production Share by Type (2011-2016)
Figure Production Market Share of Nofetumomab Merpentan by Type (2011-2016)
Figure 2015 Production Market Share of Nofetumomab Merpentan by Type
Table Global Nofetumomab Merpentan Revenue by Type (2011-2016)
Table Global Nofetumomab Merpentan Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Nofetumomab Merpentan by Type (2011-2016)
Figure 2015 Revenue Market Share of Nofetumomab Merpentan by Type
Table Global Nofetumomab Merpentan Price by Type (2011-2016)
Figure Global Nofetumomab Merpentan Production Growth by Type (2011-2016)
Table Global Nofetumomab Merpentan Consumption by Application (2011-2016)
Table Global Nofetumomab Merpentan Consumption Market Share by Application (2011-2016)
Figure Global Nofetumomab Merpentan Consumption Market Share by Application in 2015
Table Global Nofetumomab Merpentan Consumption Growth Rate by Application (2011-2016)
Figure Global Nofetumomab Merpentan Consumption Growth Rate by Application (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Nofetumomab Merpentan Market Share (2011-2016)
Table GE Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GE Healthcare Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
Figure GE Healthcare Nofetumomab Merpentan Market Share (2011-2016)
Table AREVA Med Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AREVA Med Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
Figure AREVA Med Nofetumomab Merpentan Market Share (2011-2016)
Table Bayer HealthCare Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer HealthCare Pharmaceuticals Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare Pharmaceuticals Nofetumomab Merpentan Market Share (2011-2016)
Table Cardinal Health Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cardinal Health Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
Figure Cardinal Health Nofetumomab Merpentan Market Share (2011-2016)
Table Immunomedics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Immunomedics Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
Figure Immunomedics Nofetumomab Merpentan Market Share (2011-2016)
Table Lantheus Medical Imaging Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lantheus Medical Imaging Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
Figure Lantheus Medical Imaging Nofetumomab Merpentan Market Share (2011-2016)
Table Avid Radiopharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Avid Radiopharmaceuticals Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
Figure Avid Radiopharmaceuticals Nofetumomab Merpentan Market Share (2011-2016)
Table Navidea Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Navidea Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
Figure Navidea Nofetumomab Merpentan Market Share (2011-2016)
Table Lantheus Medical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lantheus Medical Nofetumomab Merpentan Production, Revenue, Price and Gross Margin (2011-2016)
Figure Lantheus Medical Nofetumomab Merpentan Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nofetumomab Merpentan
Figure Manufacturing Process Analysis of Nofetumomab Merpentan
Figure Nofetumomab Merpentan Industrial Chain Analysis
Table Raw Materials Sources of Nofetumomab Merpentan Major Manufacturers in 2015
Table Major Buyers of Nofetumomab Merpentan
Table Distributors/Traders List
Figure Global Nofetumomab Merpentan Production and Growth Rate Forecast (2016-2021)
Figure Global Nofetumomab Merpentan Revenue and Growth Rate Forecast (2016-2021)
Table Global Nofetumomab Merpentan Production Forecast by Regions (2016-2021)
Table Global Nofetumomab Merpentan Consumption Forecast by Regions (2016-2021)
Table Global Nofetumomab Merpentan Production Forecast by Type (2016-2021)
Table Global Nofetumomab Merpentan Consumption Forecast by Application (2016-2021)